HM
Publicaties op Oncologisch.com
Early time to relapse as a survival prognosticator in nodal mature T-cell lymphomas: results from the PETAL consortium.
Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patiënten ...
Isatuximab plus PomDex versus PomDex bij myeloom: ICARIA-MM definitieve OS
BV-respons per CD30-expressie bij CTCL: ALCANZA analyse
Isatuximab plus pomalidomide-dexamethason versus pomalidomide-dexamethason bij recidief myeloom: ICARIA-MM fase III